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R456population decline only few males and
females would have to be released to
actually recall the transgenes and
revert the mosquito population to wild
type (drive out, reversion).
So far these systems have only been
described in the non-pest insect model
organism Drosophila [8], and it will take
its time until similar strategies will have
been successfully developed for
human disease vectors. In addition, it
will take enormous efforts by
international regulators in collaboration
with molecular entomologists,
ecologists, and operational pest
managers to develop clear regulatory
frameworks for the safe release of
such beneficial transgenic insects.
Nevertheless, the principal concepts to
establish transgenic refractoriness to
malaria or dengue transmission in
mosquitoes as well as to control a
locally refined spread and to recall the
transgenes are established, which
nurtures the long-standing hope that
insect transgenesis can indeed be
employed for novel strategies to fight
human vector-borne diseases.
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E-mail: ewimmer@gwdg.dehttp://dx.doi.org/10.1016/j.cub.2013.03.058Chromatin: A Tail of RepressionGenetic evidence on the role of specific histone amino acids or their
posttranslational modifications in metazoan development has been lacking.
A recent study reports that fruit flies carrying histone H3 lysine 27 (H3K27)
mutations have the same homeotic gene expression and developmental
defects as mutations in the enzyme that trimethylates H3K27.Danesh Moazed
The four canonical histones, H2A,
H2B, H3, and H4, are among the most
highly conserved eukaryotic proteins.
Between cow and pea, all but 2 of the
103 amino acids in histone H4 are the
same, and there are only 8 amino acid
differences between the yeast and
human H4 proteins. Histones package
DNA into chromatin and in keeping
with their extraordinary conservation
play important roles in nearly
all DNA transactions. That the
post-translational modifications of
histones play a central role in theregulation of chromatin structure and
transcription is a basic tenant of current
models of gene regulation. It may
come as a surprise to many that
in multicellular eukaryotes a direct
demonstration of a role for a specific
histone amino acid, or its modification,
in gene activation or silencing was
lacking until recently. In a paper
published in Science last month [1],
Muller, Herzig and colleagues now
remedy this situation by demonstrating
that a point mutation in lysine 27 of
histone H3 (H3K27) fails to silence
genes that are targeted by the
Polycomb Repressive Complex 2(PRC2), the methyltransferase that
modifies H3K27.
The basic unit of chromatin is the
nucleosome, which contains 147 base
pairs of DNA wrapped twice around
an octamer composed of four histones
[2]. Histones contain a variety of
posttranslational modifications,
which are mostly but not exclusively
concentrated on their amino termini.
These modifications provide binding
sites for proteins that mediate
downstream functions, ranging
from activation and repression of
transcription to coordination of DNA
damage repair. In addition, they affect
the interaction of the positively charged
histone tails with DNA, thereby
regulating nucleosome stability [3]. In
Drosophila, mammals, and many other
multicellular organisms, the stable
silencing of developmental regulators,
such as the homeotic master
regulators, outside of their proper
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Figure 1. The relationship between histone-modifying enzymes and their substrates in
Drosophila, S. cerevisiae, and S. pombe.
(A) In Drosophila, the E(z) subunit of the PRC2 complex methylates histone H3K27, creating a
binding site for the Polycomb (Pc) subunit of PRC1. Silencing of target genes is lost in flies or
cells homozygous for mutations of either E(z), Pc, or H3K27 to arginine. (B) In the budding
yeast S. cerevisiae, the Sir2 subunit of the SIR complex deacetylaes histone H4K16, creating
a binding site for Sir3. Silencing is lost in yeast cells carrying mutations in either Sir2, Sir3,
H4K16 to alanine, or H4K16 to glutamine. (C) In the fission yeast S. pombe, Clr4 (homolog
of Drosophila Su(var)3-9 and human Suv39h), methylates histone H3K9, creating binding sites
for chromodomain proteins Chp1, Chp2, and Swi6. Silencing is lost in cells carrying mutations
in either Clr4, any of the three chromodomain proteins, or histone H3K9 to R. Chp1 is only
required for silencing at pericentromeric heterochromatin.
Dispatch
R457domains of expression requires the
Polycomb group of genes [4,5]. The
members of this gene family encode
subunits for several complexes that
either modify histones or bind to them
or both. The Polycomb Repressive
Complex 1 (PRC1) contains the
Polycomb protein, which binds to
nucleosomes that are trimethylated
on lysine 27 of histone H3 (H3K27), a
modification that is produced by E(z),
the catalytic subunit of Polycomb
Repressive Complex 2 (PRC2) [6,7].
This, together with the observation
that flies carrying mutations in either
Polycomb or E(z) have identical
homeotic transformations, suggested
that the critical role of E(z) in silencing
involved themethylation of H3K27 [8,9].
However, histone-modifying enzymes
also have non-histone substrates
and the possibility that (E)z modifies
a non-histone substrate critical for
silencing could not be ruled out based
on the above evidence.
There is a wealth of histone
mutational data in yeast that supports
a role for posttranslational modification
of specific histone amino acids in
gene silencing (see below). In contrast
to yeast, the genomes of multicellular
organisms contain 10 to 400
copies of the genes that code for
canonical histones. These genes
are often dispersed among several
chromosomes, making histone
mutagenesis in these organisms
particularly challenging [10]. However,
in Drosophila, the histone genes
are located in a single cluster on
chromosome II containing 23 gene
units, each containing genes for
histone H1 and the four canonical
core histones [10]. Flies that are
homozygous for a deletion of this
cluster die as embryos after exhaustion
of the supply of maternally deposited
histones, but this lethality can be fully
rescued by insertion of 12 histone gene
units on chromosome III [11]. This
transgenic system made it possible
to perform mutagenesis of canonical
histone genes in a metazoan organism
for the first time.
Pengelly et al. [1] constructed
transgenic fly strains that were
heterozygous for either wild-type or
H3K27 to arginine (H3K27R) histone
transgene units and homozygous
for the deletion of the endogenous
histone gene locus. PRC2 mutant
homozygous embryos die at the end
of embryogenesis with striking anterior
to posterior homeotic transformations,which result from derepression of the
homeotic genes. However, embryos
homozygous for H3K27R mutation
lacked homeotic transformations
because their chromatin is packaged
with amixture of mutant andmaternally
deposited wild-type histone H3.
The authors therefore had to
resort to another strategy
involving the generation of Flip
recombinase-induced mitotic clones at
later stages of development. They used
this strategy to generate mutant clones
in imaginal disks, sacks of highly
programmed cells, which differentiate
to form adult structures such as wing,
leg, or abdominal segments. Strikingly,
they observed that in H3K27R
homozygous clones the targets of
PRC2 such as Ultrabithorax and
Engrailed were derepressed.
Moreover, this derepression was
accompanied by transformation of the
tissue formed by H3K27R clones in
anterior segments to more posterior
phenotypes, resembling loss of E(z).These results clearly indicate that the
identity of the amino acid at position
27 of histone H3 is critical for proper
silencing of PRC2 target genes. Since
arginine cannot be acetylated, the
results further strongly suggest that
H3K27 methylation, rather than H3K27
deacetylation, is critical for the
silencing function of this residue
(Figure 1A). Although not surprising,
this pleasing outcome is important
because it provides unequivocal
genetic evidence that the methylation
of H3K27 is critical for maintenance
of epigenetic gene expression
patterns.
The results of the above Drosophila
H3 mutagenesis experiments are
reminiscent of histone mutagenesis
experiments performed in yeast
many years ago. The first evidence in
support of a role for histones in gene
regulation came from pioneering
studies of Grunstein and colleagues
in the budding yeast Saccharomyces
cerevisiae [12]. Yeast has fewer copies
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(two for each canonical histone). So
extensive genetic analysis including
every histone side chain has been
carried out over the past few years.
Early analysis of histone tail deletions
revealed that a conserved basic region
spanning amino acids 15 to 19 in the
amino terminus of histone H4 was
specifically required for silencing of the
heterochromatic mating-type genes
but not viability [12]. Subsequent
studies showed that within this region
the acetylation state of H4 lysine 16
(H4K16) played a critical role. For
example, an H4K16 to glutamine
substitution, which mimics acetylated
lysine, disrupts silencing, while an
H4K16 to arginine substitution, which
mimics deacetylated lysine, is
tolerated. Furthermore, biochemical
and genetic studies showed that the
H4 amino terminus serves as a
binding site for the Sir3 silencing
protein (for example, see [13,14]).
This binding is regulated by
the acetylation state of H4K16, which
is deacetylated by Sir2, a highly
conserved NAD-dependent
deacetylase. These results provided a
coherent picture, supported by genetic
and biochemical studies, for how the
posttranslational modification of a
specific histone lysine controls the
binding of a silencing protein to
chromatin (Figure 1B).
Genetic evidence in support of
the importance of specific histone
amino acids in silencing also comes
from studies in the fission yeast
Schizosaccharomyces pombe.
Jenuwein and colleagues discovered
that SET domain proteins encoded
by the Drosophila gene Su(var)3-9 and
themammalian gene Suv39h contained
a methyltransferase activity that
targeted histone H3 lysine 9 (H3K9)
[15]. This methylation creates a
binding pocket for HP1 proteins and
occurs in heterochromatic DNA
domains in most eukaryotes [16,17]. In
fission yeast, the substitution of H3K9
with either alanine or arginine, as well
as deletion of the Suv39h homolog,
Clr4, results in loss of heterochromatin
[18]. Furthermore, the methylation of
H3K9 creates a binding site for the
fission yeast chromodomain proteins
Chp1, Chp2, and Swi6, all of which are
required for heterochromatic gene
silencing (Figure 1C).
Numerous examples of histone
modifications that regulate the binding
of specific proteins to chromatinhave been reported in other model
organisms. In addition to the
repressive systems describe above,
histone modifications also recruit
effectors that promote transcriptional
activation. However, with regard to
activating marks, the genetic evidence
has been harder to interpret, in
particular with regard to histone H3
methylation on lysines 4 and 36 (H3K4
and H3K36). One reason for this
difficulty is that the primary function
of these marks in yeast may involve
their role in repression of cryptic
promoters within open reading
frames (reviewed in [19]). For
example, H3K4me3 and H3K36me3
recruit different histone deacetylase
complexes to the 5’ and 3’ regions
of open reading frames that repress
cryptic transcription.
In Drosophila, the same histone
transgene system used for the
analysis of H3K27 was used by Hodl
and Basler [20] to examine the
consequences of mutating H3K4 to
alanine or arginine. Unlike the case with
H3K27 [1], imaginal disk clones
containing H3K4R mutations do not
display changes in homeotic gene
expression, even though both sources
of potential H3K4 methylation, H3.2
and H3.3, were simultaneously
mutated. In this case, H3K4
trimethylation levels were reduced to a
level below the immunoflourescence
detection limit in the homozygous
disk clones. It remains possible that
the quantitative requirement of H3K4
methylation for active transcription
could be less than H3K27 methylation
for gene repression. Alternatively,
Trithorax may act on non-H3K4
targets in disks, or the role of H3K4
methylation in transcriptional
activation may be redundant with other
modifications. To address these
possibilities, it would be interesting to
test whether disk clones homozygous
for mutations in Trithorax, the
Drosophila H3K4 methyltransferase
required for maintenance of homeotic
gene expression, have defects in
homeotic gene expression.
We can now look forward to a
more complete genetic dissection of
the role of histones in gene regulation
in Drosophila. More importantly,
positive genetic verification as
reported for the H3K27 mutation
highlights the importance of ongoing
mechanistic studies on the role of
histones and their posttranslational
modifications in regulation ofchromatin structure and gene
expression.References
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Centrosome NumbersAccurate control of centrosome number is critical for the maintenance of
genomic integrity. A recent study reveals that the deubiquitinating enzyme
USP33 regulates centrosome biogenesis by stabilizing the centriolar protein
CP110.Felix Ba¨renz and Ingrid Hoffmann*
The centrosome is a non-membrane-
bound organelle found in most animal
cells. It has several important
functions, including control of cilia
formation, microtubule organization
and nucleation, spindle assembly
and transport of organelles and
vesicles. Centrosomes consist of two
centrioles, which are barrel-shaped
microtubule-based structures
surrounded by an electron-dense
matrix, the pericentriolar material
(PCM). Duplication of centrioles must
occur in coordination with DNA
synthesis only once per cell cycle and
duplication involves the assembly of a
new daughter centriole (procentriole)
next to the proximal end of the mother
centriole [1]. In human cells, hSAS-6,
STIL, CEP135, CPAP, g-tubulin, and
CP110 have been identified as
essential factors required at the onset
of centriole biogenesis for centriole
formation [2,3]. The newly formed
procentrioles then start to elongate,
increase in length during S phase, and
are fully assembled in G2 phase of the
cell cycle. A new study by Li et al. [4]
now reports a role for deubiquitination
in the stabilization of CP110 during
S/G2 phase.
The protein CP110 was first
identified as a Cdk2 substrate required
for centrosome overduplication in
S-phase-arrested cells [5]. It is
associated with the growing centriolar
distal tips, forming a cap beneath
which centrioles elongate through the
insertion of a/b-tubulin [2]. Depletion of
CP110 or overexpression of CPAP was
shown to induce centriole elongation,
suggesting that CPAP and CP110 play
opposing roles in controlling centriolelength [6–8]. CP110 in a complex with
its regulator Cep97 also plays an
additional role in preventing cilia
formation through the inhibition of
centriole to basal body conversion [9].
CP110 protein levels are tightly
controlled during the cell cycle in order
to prevent centriole duplication errors.
CP110 physically associates with the
F-box protein cyclin F on centrioles
during the G2 phase of the cell cycle
and is then ubiquitinated by the
SCFCyclinF E3 ubiquitin ligase complex,
leading to its degradation [10]. The new
study by Li et al. [4] now reports that
deubiquitination is also an important
mechanism for the regulation of CP110
protein levels during the cell cycle.
Polyubiquitinated proteins that are
marked for degradation can be
stabilized in response to the activity
of deubiquitinating enzymes
(DUBs) — proteases that remove the
polyubiquitin chain. Around 100 active
DUBs are found in the human genome
[11] and, as a result of their ability to
reverse ubiquitination, these enzymes
control a broad range of key cellular
processes. Li et al. [4] report that
the DUB USP33 (ubiquitin-specific
protease 33, also known as VDU1)
binds to CP110 and specifically
deubiquitinates CP110 in a cell-cycle-
dependent manner, thus counteracting
SCFCyclinF ubiquitin ligase
activity (Figure 1).
Although several SCF ubiquitin ligase
complexes have been recently shown
to regulate centrosome biogenesis
[12], DUBs had not been demonstrated
to be involved in the regulation of this
process until now. Both USP33 and the
highly related USP20 (also known as
VDU2) interact with CP110, but USP33
has a greater impact on CP110 levelsthan USP20. USP33 and USP20 are
mainly localized to the cytoplasm, in
particular to the endoplasmic reticulum
[13]. USP33 additionally localizes to the
proximal end of centrioles, whereas
CP110 is a distal-end-capping protein,
suggesting that only a subpopulation of
CP110 interacts with USP33. USP33
localizes to centrosomes primarily
during S and G2 phase of the cell cycle
similar to CP110. Centriolar targeting
of USP33 is at least in part dependent
on CP110 because depletion of CP110
reduced USP33 localization to the
centrosome. USP33 specifically
deubiquitinates CP110 both in vitro and
in vivo. The amino-terminal domain of
CP110 interacts with the catalytic
domain of USP33 and is required for
USP33-mediated deubiquitination.
As CP110 is a crucial player in
centriole duplication, it is intriguing to
ask whether centriole duplication
would also be affected in the absence
of the CP110-stabilizing effects of
USP33. Li et al. [4] found that USP33
depletion did not inhibit normal
centriole duplication through loss of
centrioles: instead, loss of USP33
inhibited centrosome re-duplication. In
some cell lines, for example U2OS,
centrosome re-duplication can
be induced by the addition of
hydroxyurea, which promotes
cell-cycle arrest at the G1/S phase
transition but does not affect
centrosome duplication and thereby
results in an increase in centrosome
numbers. A similar effect on
centrosome duplication is caused by
CP110 depletion [5]. Intriguingly,
co-depletion of USP33 and SCFcyclinF
rescued the mitotic defects caused
upon siRNA-mediated downregulation
of SCFcyclinF [4]. Therefore, opposing
activities of E3 ubiquitin ligases and
DUBs that both target key regulators of
centriole duplication may represent a
general mechanism for regulating the
levels of those factors during the cell
cycle and centriole biogenesis.
Supernumerary centrosomes are
frequently found in cancer cells. During
cell division too many centrosomes
